Healthcare and Life Science
Moving on up: Guardtech Group celebrate continued growth with switch to stunning new home
Cleanroom construction experts putting finishing touches on impressive new Guardtech House HQ in Haverhill. ...
TherageniX and University of Nottingham Awarded £995K Innovate UK grant to develop powdered gene therapy for bone regeneration
London, UK, and Nottingham, UK - TherageniX, a University of Nottingham spin out pioneering a dry powder gene therapy formulation for bone graft augmentation, and its collaborator, the University of Nottingham, have been awarded a £995,000 grant from Innovate UK, the UK’s innovation age...
Five ways to combat new job nerves when you hire
Studies show that 80% of people are nervous before starting a new job. Having spent time and money on the recruitment process, you'll want to make sure your new employees have a smooth onboarding process and hit the ground running as soon as possible. ...
NIHR BioResource - Celebrating our Centres - Birmingham
The NIHR BioResource Centre Birmingham team have been busy on the ground engaging with local communities at events, talking about the NAFLD BioResource and patient participation on local radio, and getting professional videos made to promote diversity, participation and the value of res...
Living with SANDO – a long road to diagnosis
42-year-old Mark shares his story living with Sensory Ataxic Neuropathy, Dysarthria, and Ophthalmoparesis (SANDO) disease, a rare mitochondrial condition that affects the brain, muscles, nerves and eyes. He discusses everything from the long road to diagnosis, his brother developing sym...
Optibrium acquires BioPharmics LLC, expanding its 3D drug design and visualisation offering
BioPharmics’ Drs Ajay Jain (CEO) and Ann Cleves (Director of Applied Science) join the Optibrium team as Vice Presidents in the newly-created BioPharmics Division. ...
NIHR IMID BioResource recruits its 10,000th volunteer in major milestone
The platform for research into Immune-Mediated Inflammatory Diseases (IMIDs) has now signed up 10,000 participants nationwide. Find out about the value of having such a large cohort and what it means for future research studies into IMIDs. ...
Intellegens and CPI awarded £1.6m Innovate UK grant to advance manufacture of oligonucleotide therapeutics with machine learning
Cambridge, UK - Intellegens, a company applying machine learning (ML) to accelerate innovation in R&D, announces that it has secured a £1.6m grant from Innovate UK, part of UK Research and Innovation (UKRI), to apply ML in the emerging field of oligonucleotide therapies. ...
CN Bio appoints Dr. Tomasz Kostrzewski as Chief Scientific Officer
Cambridge, UK, 30th August 2023: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the appointment of Dr. Tomasz Kostrzewski as Chief Scientific Officer. Previously Vice President of Sci...
Key human bladder cancer genes pinpointed in cats and dogs
Key bladder cancer genes have been uncovered through studying the cancers in cats and dogs, in a significant stride for finding which of many mutations are the most important in the cancer’s development. ...